series-c-plus
Stage
2
Investors
About
ForEndo Pharma develops novel therapeutics focused on treating endocrine and metabolic disorders, specializing in drug candidates targeting hormone-related pathways.
Explore ForEndo Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.